Zobrazeno 1 - 10
of 42
pro vyhledávání: '"Sophie Lange"'
Autor:
Arslan Sajid Raja, Sophie Lange, Maxim Karpov, Kai Shi, Xin Fu, Raphael Behrendt, Daniel Cletheroe, Anton Lukashchuk, Istvan Haller, Fotini Karinou, Benn Thomsen, Krzysztof Jozwik, Junqiu Liu, Paolo Costa, Tobias Jan Kippenberg, Hitesh Ballani
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-7 (2021)
Optical technologies could enable fast and power-efficient networks for data centers. Here, the authors report Si3N4 microcomb based ultrafast photonic switching to provide enhanced performance for data center applications.
Externí odkaz:
https://doaj.org/article/2a833dd80faa48e68fb98c4d62b336fc
Autor:
Sophie Lange
Publikováno v:
Worldwide Waste, Vol 3, Iss 1 (2020)
From a German-German Bargain to the Creation of an Environmental Problem in the 1980s In the 1970s, West Berlin started to transport its waste to East-German dumpsites. By the 1980s, Hamburg and other West German municipalities had followed suit, dep
Externí odkaz:
https://doaj.org/article/15d63f7070d146c980a1c7201beede60
Autor:
Dominik Bettinger, Eleni Gkika, Michael Schultheiss, Nicolas Glaser, Sophie Lange, Lars Maruschke, Nico Buettner, Simon Kirste, Ursula Nestle, Anca-Ligia Grosu, Robert Thimme, Thomas B. Brunner
Publikováno v:
BMC Cancer, Vol 18, Iss 1, Pp 1-9 (2018)
Abstract Background As stereotactic body radiation therapy (SBRT) has shown to be effective and safe in patients with hepatocellular carcinoma (HCC), the aim of our propensity score matched analysis was to evaluate the efficacy of SBRT in comparison
Externí odkaz:
https://doaj.org/article/b7eac5ebbd354b8eb982066caecede70
Autor:
Angela Kuhla, Sophie Lange, Carsten Holzmann, Fabian Maass, Jana Petersen, Brigitte Vollmar, Andreas Wree
Publikováno v:
PLoS ONE, Vol 8, Iss 7, p e68778 (2013)
Caloric restriction (CR) is argued to positively affect general health, longevity and the normally occurring age-related reduction of cognition. This issue is well examined, but most studies investigated the effect of short-term periods of CR. Herein
Externí odkaz:
https://doaj.org/article/ec57ed375a31422da718b6448ca205da
Autor:
Bianca Raffaelli, Elisabeth Storch, Lucas Hendrik Overeem, Maria Terhart, Mira Pauline Fitzek, Kristin Sophie Lange, Uwe Reuter
Publikováno v:
Neurology. 100:e1825-e1835
Autor:
Kristin Sophie Lange, Gabrielle Tuloup, Claire Duflos, Claire Gobron, Cécilia Burcin, Lucas Corti, Caroline Roos, Anne Ducros, Jérôme Mawet
Publikováno v:
Journal of Neurology.
Introduction Reversible cerebral vasoconstriction syndrome (RCVS) has a heterogenous clinical and radiological presentation. We investigated whether RCVS complications vary according to age. Patients and methods In a pooled French cohort of 345 patie
Autor:
Lucas Hendrik Overeem, Kristin Sophie Lange, Mira Pauline Fitzek, Anke Siebert, Maureen Steinicke, Paul Triller, Ja Bin Hong, Uwe Reuter, Bianca Raffaelli
Publikováno v:
Frontiers in Neurology. 14
BackgroundTherapeutic options for migraine prevention in non-responders to monoclonal antibodies (mAbs) targeting Calcitonin Gene-Related Peptide (CGRP) and its receptor are often limited. Real-world data have shown that non-responders to the CGRP-re
Publikováno v:
The European Experience ISBN: 9781800648708
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::67c5b941bb636c99f748a11a29036586
https://doi.org/10.11647/obp.0323.51
https://doi.org/10.11647/obp.0323.51
Publikováno v:
The European Experience ISBN: 9781800648708
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4b58b3379669409105ac5a43f4967c3f
https://doi.org/10.11647/obp.0323.50
https://doi.org/10.11647/obp.0323.50
Autor:
Hannah Lyons, Fatemeh Farham, Uwe Reuter, Deirdre M. Boucherie, Angelo TORRENTE, Dilara Onan, Marta Waliszewska-Prosół, Kristin Sophie Lange, Karol Marschollek, Umberto Pensato, Elisabeth Storch
Publikováno v:
Journal of Headache and Pain. 24(1)
Introduction Migraine prophylactic therapy has changed over recent years with the development and approval of monoclonal antibodies (mAbs) targeting the calcitonin gene-related peptide (CGRP) pathway. As new therapies emerged, leading headache societ